CereVasc, Inc. announced it has completed the initial closing of an $85 million Series C financing. The clinical-stage ...
Medical Device Network on MSN
CereVasc raises $85M to advance hydrocephalus treatment
CereVasc’s eShunt is an implantable system designed to treat normal pressure hydrocephalus by draining excess cerebrospinal ...
CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results